Immunic, Inc. IMUX
7.64 USD +0.30 +4.09%
As of Nov 3, 12:00 PM ET
- Open
- 7.61
- Prev close
- 7.34
- Mkt cap
- 104.24M
- Vol
- 69.79K
- Avg vol
- 338.68K
- EPS
- -3.83
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 7.35
- High
- 7.87
- Forward P/E
- -1.67
- Beta
- 1.88
- Short ratio
- 4.69
- Inst. own
- 64.85%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.24
- 200-d avg
- 1.32
- 1y target
- 12.79
MAX chart
Chart tools
Chart is warming up
The all-time price history for IMUX has not been loaded yet. Try again in a moment.
Altman Z-Score
-5.40 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
P/E -0.9×
P/S 0.0×
P/B -12.5×
P/FCF -1.0×
EV/EBITDA -0.7×
EV/Sales 0.0×
FCF Yield -103.4%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE 1456.2%
ROIC 1693.4%
ROA -404.0%
Revenue 0.0%
Operating Income -5.3%
EPS (diluted) 37.8%
Free Cash Flow -1.1%
Current Ratio 0.7×
Quick Ratio 0.7×
Debt / Equity -0.1×
Net Debt / EBITDA 0.2×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31
